World Of Taxonomy
0003-0371Level 3

NULOJIX (BELATACEPT)

**Product type:** Human Prescription Drug

**Active ingredient:** BELATACEPT

**Strength:** 250 mg/1

**Dosage form:** Injection, Powder, Lyophilized, For Solution

**Route:** Intravenous

**Labeler:** E.R. Squibb & Sons, L.L.C.

**Marketing category:** BLA (BLA125288)

**Pharmacologic class:** CD80-directed Antibody Interactions [MoA], CD86-directed Antibody Interactions [MoA], Selective T Cell Costimulation Blocker [EPC], T Lymphocyte Costimulation Activity Blockade [PE]

GET/api/v1/systems/ndc_fda/nodes/0003-0371
Official DownloadPublic Domain (US Government)Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.